Psyence Biomedical PBM
NASDAQ PBM
$4.57 +0.05 (+1.08%)
As of: Oct 22, 2026 · 9:41 AM EDT

Psyence Biomedical (PBM) EBIT (2023 - 2025)

Updated

Psyence Biomedical's EBIT was -$6.24 million in the year ended Mar 31, 2026, compared with -$3.67 million a year earlier.

Analysis

Psyence Biomedical (PBM) EBIT (2023 - 2025) Analysis & Trends

From the year ended Mar 31, 2023 onward, Psyence Biomedical has reported EBIT for 4 years.

  • Per Business Quant data, EBIT in earlier years was -$3.67 million in the year ended Mar 31, 2025, -$2.8 million in the year ended Mar 31, 2024 and -$3.23 million in the year ended Mar 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn 7.14 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn 6.43 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn 4.27 Bn
10 Psyence Biomedical 2.52 Mn -20.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.50 Mn
Sep 30, 2024 -1.15 Mn
Sep 30, 2023 -148,229.00
API Access

Psyence Biomedical EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=PBM&period=max&api_key=YOUR_API_KEY